Abstract
The most consistantly reported alteration of multidrug-resistant carcinoma cells is the overexpression of a membrane glycoprotein, termed P-glycoprotein. In this study we examined whether the strong intrinsic chemotherapy resistance of glial tumors might be related to the expression of the MDR1 gene which codes for P-glycoprotein. Fourteen glial tumors were examined immunohistochemically using the monoclonal antibody C219. In addition, RNA samples of 11 of these tumors were analysed using a sensitive Northern blot assay. P-glycoprotein is expressed in all 14 glial tumors; the number of stained tumor cells, however, varied considerably ranging from 0.3% to 15%. There was no correlation between the number of MDR1-positive cells and the histological malignancy. Varying amounts of MDR1 mRNA were detectable in 7 from 11 examined tumors. The results of our study show that the MDR1 gene is expressed in human glial tumors and suggest that the multidrug transporter may contribute to the clinical non-responsiveness of these tumors to chemotherapy.
| Original language | English |
|---|---|
| Pages (from-to) | 516-519 |
| Number of pages | 4 |
| Journal | Acta Neuropathologica |
| Volume | 82 |
| Issue number | 6 |
| DOIs | |
| State | Published - Nov 1991 |
| Externally published | Yes |
Keywords
- Glial tumor
- Immunohistochemistry
- Multidrug resistance
- P-glycoprotein
- RNA analysis